Page 9 of 10 SEC Filing AGREEMENT The undersigned agree that this Schedule 13G dated March 1, 2016 relating to the Common Stock, par value $0.001 per share of Nevro Corp. shall be filed on behalf of the undersigned. March 1, 2016 (Date) BROADFIN CAPITAL, LLC By: /s/ Kevin Kotler (Signature) Kevin Kotler, Managing Member (Name/Title)
March 1, 2016 (Date) BROADFIN HEALTHCARE MASTER FUND, LTD. By: /s/ Kevin Kotler (Signature) Kevin Kotler, Director (Name/Title)
March 1, 2016 (Date) By: /s/ Kevin Kotler (Signature) Kevin Kotler (Name/Title)
The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See s.240.13d-7 for other parties for whom copies are to be sent. Attention. Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001). Follow Nevro Corp (NYSE:NVRO)
Follow Nevro Corp (NYSE:NVRO)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
AGREEMENT
The undersigned agree that this Schedule 13G dated March 1, 2016 relating to the Common Stock, par value $0.001 per share of Nevro Corp. shall be filed on behalf of the undersigned.
| March 1, 2016 | |
| (Date) | |
| BROADFIN CAPITAL, LLC | |
| By: /s/ Kevin Kotler | |
| (Signature) | |
| Kevin Kotler, Managing Member | |
| (Name/Title) |
| March 1, 2016 | |
| (Date) | |
| BROADFIN HEALTHCARE MASTER FUND, LTD. By: /s/ Kevin Kotler | |
| (Signature) | |
| Kevin Kotler, Director | |
| (Name/Title) |
| March 1, 2016 | |
| (Date) | |
| By: /s/ Kevin Kotler | |
| (Signature) | |
| Kevin Kotler | |
| (Name/Title) |
The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.
Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See s.240.13d-7 for other parties for whom copies are to be sent.
Attention. Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).
Follow Nevro Corp (NYSE:NVRO)
Follow Nevro Corp (NYSE:NVRO)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
